1. Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases 
Xavier Roblin, Hubert Marotte, Melanie Rinaudo, Emilie Del Tedesco, Amelie Moreau, Jean Marc Phelip, Christian Genin, Laurent Peyrin–Biroulet, Stephane Paul 
Clinical Gastroenterology and Hepatology 
Volume 12, Issue 1, Pages e2 (January 2014)
DOI: /j.cgh
Copyright © 2014 AGA Institute Terms and Conditions

2. Figure 1
(A) Comparison of ADA trough levels between IBD patients with MH and those without MH (P < .005). (B) Quartiles of ADA trough levels for the obtention of MH (P = .001).
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions

3. Figure 2
Comparison of ADA trough levels between IBD patients with MH and those without MH in CD and UC (P = .04).
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions

4. Figure 3
ROC curves for trough levels of ADA in IBD patients (MH vs no MH). NPV, negative predictive value; PPV, positive predictive value.
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions

5. Supplementary Figure 1
(A) Comparison of ADA trough levels between IBD patients in clinical remission (CR) and those with active disease (P = .012). (B) Quartiles of ADA values for the obtention of clinical remission (P = .001).
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions

6. Supplementary Figure 2
ROC curves for trough levels of ADA in IBD patients (CR vs no CR). CR, clinical remission; NPV, negative predictive value; PPV, positive predictive value.
Clinical Gastroenterology and Hepatology  , e2DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions